{"resourceType":"ValueSet","id":"2.16.840.1.113883.17.4077.2.1007","meta":{"versionId":"32","lastUpdated":"2020-09-09T01:00:54.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.17.4077.2.1007","version":"20200909","name":"Coagulopathies Excluding Thrombocytopenia","status":"active","date":"2020-09-09T01:00:54-04:00","publisher":"ACEP/AMA-PCPI Steward","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","concept":[{"code":"D65","display":"Disseminated intravascular coagulation [defibrination syndrome]"},{"code":"D66","display":"Hereditary factor VIII deficiency"},{"code":"D67","display":"Hereditary factor IX deficiency"},{"code":"D68.0","display":"Von Willebrand's disease"},{"code":"D68.1","display":"Hereditary factor XI deficiency"},{"code":"D68.2","display":"Hereditary deficiency of other clotting factors"},{"code":"D68.311","display":"Acquired hemophilia"},{"code":"D68.312","display":"Antiphospholipid antibody with hemorrhagic disorder"},{"code":"D68.318","display":"Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors"},{"code":"D68.32","display":"Hemorrhagic disorder due to extrinsic circulating anticoagulants"},{"code":"D68.4","display":"Acquired coagulation factor deficiency"},{"code":"D68.8","display":"Other specified coagulation defects"},{"code":"D68.9","display":"Coagulation defect, unspecified"},{"code":"D69.1","display":"Qualitative platelet defects"},{"code":"D69.41","display":"Evans syndrome"},{"code":"D69.51","display":"Posttransfusion purpura"},{"code":"D69.8","display":"Other specified hemorrhagic conditions"},{"code":"D69.9","display":"Hemorrhagic condition, unspecified"}]}]}}